These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6738078)

  • 1. [Comparative biochemical and ultrastructural study of the hepatic response induced in the rat by 2 hypolipemic agents: clofibrate and itanoxone].
    Gendre PM; Marcelon G; Delhon A; Lauressergues H; Fauran F
    J Pharmacol; 1984; 15(2):209-22. PubMed ID: 6738078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative ultrastructural study of rat hepatocytes after treatment with the hypolipidemic agents probucol, clofibrate, and fenofibrate.
    Barnard SD; Molello JA; Caldwell WJ; LeBeau JE
    J Toxicol Environ Health; 1980 May; 6(3):547-57. PubMed ID: 7420463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
    Stevens TJ; Stafford WW; Day CE; Block EM
    Artery; 1983; 12(2):81-94. PubMed ID: 6678582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hypolipidaemic drugs on hepatomegaly and micro-bodies in the rat. A new approach to the nature of hepatic peroxisomal proliferation.
    Sim AK; Spencer A; Metz G; Rushton B
    Arzneimittelforschung; 1981; 31(7):1119-26. PubMed ID: 7196761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
    Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
    Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats.
    Ohata I; Sakamoto N; Nitatori R; Maeno H
    Arzneimittelforschung; 1983; 33(2):237-41. PubMed ID: 6682662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of orotic acid-induced fatty liver in rats by clofibrate.
    Novikoff PM; Edelstein D
    Lab Invest; 1977 Feb; 36(2):215-31. PubMed ID: 839735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clofibrate withdrawal on peroxisomes in mouse hepatocytes.
    Meijer J; Starkerud C; Afzelius BA
    Eur J Cell Biol; 1993 Apr; 60(2):291-9. PubMed ID: 8330627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation of peroxisomes in pericentral hepatocytes of rat liver after administration of a new hypocholesterolemic agent (BM 15766). Sex-dependent ultrastructural differences.
    Baumgart E; Stegmeier K; Schmidt FH; Fahimi HD
    Lab Invest; 1987 May; 56(5):554-64. PubMed ID: 3573722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofibrate hypocholesterolemia associated with increased hepatic copper.
    Klevay LM
    Drug Nutr Interact; 1983; 2(2):131-7. PubMed ID: 6678750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of clofibrate on intracellular enzyme distribution in the rat liver].
    Panchenko LF; Popova SV; Pirozhkov SV; Antonenkov VD
    Tsitologiia; 1983 Nov; 25(11):1302-8. PubMed ID: 6659071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ethanol and clofibrate on the activity of lipid catabolism enzyme systems in rat liver].
    Antonenko VD; Popova SV; Panchenko LF
    Farmakol Toksikol; 1983; 46(5):86-90. PubMed ID: 6138280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clofibrate on plasma lipid concentration and liver malic enzyme gene expression in rats with experimental chronic renal failure.
    Korczyńska J; Stelmańska E; Nieweglowski T; Szołkiewicz M; Rutkowski B; Swierczyński J
    Pol J Pharmacol; 2000; 52(4):291-7. PubMed ID: 11345485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of 4-(4'-chlorobenzyloxy) benzyl nicotinate (KCD-232) on lipid metabolism in rats and mice].
    Okada K; Mochizuki T; Shinohara Y; Takahashi S; Takagi K; Irikura T
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):331-43. PubMed ID: 6745812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.